Vimarsana
Biggest News Aggregation in the World

Page 2 - Celularity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Celularity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Celularity Today - Breaking & Trending Today

Celularity Inc.'s (NASDAQ:CELU) top owners are public companies with 35% stake, while 35% is held by individual investors - Vimarsana News

Celularity Inc.'s (NASDAQ:CELU) top owners are public companies with 35% stake, while 35% is held by individual investors

Key Insights The considerable ownership by public companies in Celularity indicates that they collectively have a...

Source: yahoo.com
Celularity CEO Says 2023 Revenue to Rise About 23% to 27% - Vimarsana News

Celularity CEO Says 2023 Revenue to Rise About 23% to 27%

By Will Feuer Celularity Chief Executive Robert Hariri said the biotechnology company expects to report 2023 revenue that is 23% to 27% higher than the...

Celularity Inc. (NASDAQ:CELUW) Short Interest Up 149.6% in December - Vimarsana News

Celularity Inc. (NASDAQ:CELUW) Short Interest Up 149.6% in December

Celularity Inc. (NASDAQ:CELUW – Get Free Report) was the recipient of a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 31,700 shares, an increase of 149.6% from the December 15th total of 12,700 shares. Based on an average daily trading volume, of 66,600 shares, […]

Celularity Gets Commercialization Deal For Oral Healthcare Products - Vimarsana News

Celularity Gets Commercialization Deal For Oral Healthcare Products

By Ben Glickman Celularity on Thursday confirmed that it had entered a commercialization agreement with BioCellgraft to make biomaterial products for dental...

Celularity Expects 4Q Product, Services Sales to Nearly Triple - Vimarsana News

Celularity Expects 4Q Product, Services Sales to Nearly Triple

By Ben Glickman Celularity is expecting fourth-quarter sales from its biomaterial products and biobanking businesses to nearly triple. The Florham Park,...